Today, the Centers for Disease Control and Prevention (CDC) published data from the 2019 cycle (June 2019-May 2020) of the Medical Monitoring Project (MMP). The format of the report is now available for the first time in a digital first...
This dear Colleague Letter announces the second major round of CDC funding delivered to state and local health departments as part of the EHE initiative.
A dual therapy of two drugs that are antibodies not to HIV, but to host proteins that help to perpetuate HIV infection, has reduced viral load in monkeys chronically infected with a highly pathogenic monkey analogue of HIV, the 11th IAS...
Paired studies in Brazil with transgender women who took gender-affirming hormone therapy (GAHT) and PrEP have found that levels of GAHT were not affected by PrEP, nor PrEP levels by GAHT, to a degree likely to make a clinical difference.
Cabotegravir injections every other month are a highly effective pre-exposure prophylaxis (PrEP) option for women – and may be even more effective than reported in an earlier analysis, according to research presented this week at the...
Transgender and gender-diverse activists and researchers, in partnership with the advocacy organisation AVAC, introduced a powerful manifesto to align HIV prevention research with their current realities and needs, entitled No Data No...
A six-month oral treatment regimen that limits exposure to the toxic drug linezolid can achieve a high cure rate in people with highly drug-resistant tuberculosis (TB), Dr Francesca Conradie of Sizwe Tropical Diseases Hospital,...
People who start antiretroviral treatment early, before they develop extensive immune system damage, have a smaller HIV viral reservoir, which may improve prospects for a functional cure, according to studies presented this week at the...
A study at the 11th International AIDS Society Conference on HIV Science (IAS 2021) is the first to investigate drug levels and drug resistance in people who become infected with HIV despite taking PrEP in the real-world setting of four...
Simple measures to improve the ordering and turnaround of viral load tests in Uganda significantly improved viral suppression after one year, a cluster-randomised trial reported this week at the 11th International AIDS Society Conference...
Fewer people living with HIV in six sub-Saharan African countries experienced interruptions to their HIV treatment during and after COVID-19-related lockdowns than before the pandemic hit, according to a PEPFAR study presented to the...
The long-acting injectable HIV medications cabotegravir and rilpivirine, which are administered by a healthcare provider once a month, can be successfully implemented in health practises in the United States, according to a study...
A detectable viral load together with a CD4 count below 500 put people with HIV at greater risk of severe COVID-19, a study of COVID-19 cases in 16 Spanish hospitals reported yesterday at the 11th International AIDS Society Conference on...
People experiencing homelessness or unstable housing differ in the types of HIV care they prefer, with a majority favouring flexibility while about a third wanted to consistently see the same provider, according to a study presented this...
While PrEP users in Brazil and Mexico had low numbers of new HIV infections, there were a high number of breakthrough infections in Peru, according to updates from the large-scale Latin-American PrEP demonstration project, ImPrEP,...
People living with HIV have more cardiovascular risk factors and are at heightened risk of cardiovascular disease, the 11th International AIDS Society Conference on HIV Science (IAS 2021) heard this week. People with HIV under the age of...
Early results from a small study suggest that twice-a-year injections of lenacapavir, an experimental HIV capsid inhibitor, can be used as part of a combination regimen for people starting HIV treatment, the 11th International AIDS...
Successful approaches to managing HIV in adolescents and young adults were reported by researchers from two sub-Saharan African countries at the 11th International AIDS Society Conference on HIV Science this week.
A qualitative study sought to understand healthcare workers’ perspectives on patients who disengage from antiretroviral therapy (ART) at a clinic in Cape Town, South Africa. Results, presented this week to the 11th International AIDS...
People living with HIV should be prioritised for COVID-19 vaccination, the World Health Organization (WHO) said last week, following the release of research at the 11th International AIDS Society Conference on HIV Science (IAS 2021)...
Reports of rape and sexual violence increased among women and girls in Uganda during the COVID-19 pandemic, while uptake of post-exposure prophylaxis (PEP) decreased. These outcomes, reported to the 11th International AIDS Society...
Hepatitis C has been almost eliminated as a health problem for people living with HIV in the Netherlands due to direct-acting antiviral treatment, researchers reported this week at the 11th International AIDS Society Conference on HIV...
In the final report from the Start Free, Stay Free, AIDS Free initiative, UNAIDS and partners warn that progress towards ending AIDS among children, adolescents and young women has stalled and none of the targets for 2020 were met.
Even without traditional cardiovascular risks factors such as smoking and obesity, people under 40 with HIV have substantially higher CVD risks than the general public. Medscape Medical News
Preliminary results presented at the International AIDS Society (IAS) 2021 conference, show that a novel intervention and implementation strategies, including education programs and capacity building can reduce the number of deaths from...
A new randomized trial bolsters efficacy evidence for dolutegravir and finds no benefit in switching from tenofovir in second-line HIV treatment. Medscape Medical News
Since antiretroviral therapy (ART) for HIV was introduced in 1996, AIDS-related morbidity and mortality has declined significantly. People living with HIV are now expected to live nearly as long as people without HIV. Despite these...
Nearly 40 million people worldwide live with HIV (human immunodeficiency virus), and this number increases every year as more individuals acquire the incurable infection. There is no vaccine to prevent HIV infection and the virus, if...
Mindful of the pitfalls of previous monkey studies on HIV, the researchers designed the trial to make it difficult for the drug combination to show better results than might be realistic in humans. Medscape Medical News
A research group led by Prof. Li Guohui from the Dalian Institute of Chemical Physics (DICP) of the Chinese Academy of Sciences (CAS), in collaboration with Prof. Chen Jianfeng's group from Shanghai Institute of Biochemistry and Cell...
Worldwide data from WHO suggest that HIV itself is an independent risk factor for severe COVID-19, but viral load and CD4 weren't part of the calculations. Medscape Medical News
The AstraZeneca-Oxford COVID-19 vaccine is effective in people living with HIV, at least in the short term, according to an open-label substudy within the protocol of a larger phase 2/3 trial. Reuters Health Information
Adolescent girls and young women can and will use HIV prevention products with consistency, according to interim results of a study of two different methods: daily use of the antiretroviral (ARV) tablet Truvada as oral pre-exposure...
To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions for TB patients worldwide, a new consortium of 30 partners from 13 countries has officially launched.
Data are presented for diagnoses of HIV infection reported to CDC through March 2021 and preexposure prophylaxis (PrEP) data reported through December 2020.
Adolescent girls and young women can and will use HIV prevention products with consistency, according to interim results of a study of two different methods: daily use of the antiretroviral (ARV) tablet Truvada as oral pre-exposure...
At 15, Autumn Fuernisen is dying. She was diagnosed at age 11 with a rare degenerative brain disorder that has no known cure or way to slow it down: juvenile-onset Huntington's disease.
The Food and Drug Administration's approval in June of a drug purporting to slow the progression of Alzheimer's disease was widely celebrated, but it also touched off alarms.
A presentation at this year's European Congress on Clinical Microbiology & Infectious Diseases (ECCMID), held online this year, will discuss the growing evidence that the beta SARS-CoV-2 variant first identified in South Africa is...
Spanish doctors highlight the importance of targeting and testing older adults for HIV in a case report being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) held online this year. Dr. Enrique...
An observational cohort study finds that mortality among persons entering HIV care decreased dramatically between 1999 and 2017, with the largest decrease seen between 2011 and 2017. Those entering HIV care remained at modestly higher...
New research from the Kirby Institute at UNSW Sydney shows that HIV transmissions are at historically low rates among almost 10,000 high-risk gay and bisexual men on pre-exposure prophylaxis (PrEP), the HIV prevention medication. Low HIV...
Newly published research shows that a screening program in the University of Cincinnati Medical Center Emergency Department helped detect an outbreak of HIV among persons who inject drugs in Hamilton County, Ohio, from 2014-18.
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced that findings from a sub-study of REPRIEVE (A5332/A5332s, an international clinical trial studying heart disease prevention in people living...
Early in this century, post-SARS, and in a period when China started allowing more students and scientists to study abroad, collaboration and exchange between American and Chinese scientists blossomed.
New biomarkers that predict HIV remission after antiretroviral therapy (ART) interruption are critical for the development of new therapeutic strategies that can achieve infection control without ART, a condition defined as functional...